7-147888727-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_014141.6(CNTNAP2):​c.2099-14838T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.442 in 131,636 control chromosomes in the GnomAD database, including 14,836 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.44 ( 14836 hom., cov: 27)

Consequence

CNTNAP2
NM_014141.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.572

Publications

14 publications found
Variant links:
Genes affected
CNTNAP2 (HGNC:13830): (contactin associated protein 2) This gene encodes a member of the neurexin family which functions in the vertebrate nervous system as cell adhesion molecules and receptors. This protein, like other neurexin proteins, contains epidermal growth factor repeats and laminin G domains. In addition, it includes an F5/8 type C domain, discoidin/neuropilin- and fibrinogen-like domains, thrombospondin N-terminal-like domains and a putative PDZ binding site. This protein is localized at the juxtaparanodes of myelinated axons, and mediates interactions between neurons and glia during nervous system development and is also involved in localization of potassium channels within differentiating axons. This gene encompasses almost 1.5% of chromosome 7 and is one of the largest genes in the human genome. It is directly bound and regulated by forkhead box protein P2, a transcription factor related to speech and language development. This gene has been implicated in multiple neurodevelopmental disorders, including Gilles de la Tourette syndrome, schizophrenia, epilepsy, autism, ADHD and intellectual disability. [provided by RefSeq, Jul 2017]
CNTNAP2 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AR, AD Classification: DEFINITIVE, NO_KNOWN Submitted by: ClinGen
  • cortical dysplasia-focal epilepsy syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Illumina, Labcorp Genetics (formerly Invitae), Orphanet, G2P, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.457 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_014141.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CNTNAP2
NM_014141.6
MANE Select
c.2099-14838T>C
intron
N/ANP_054860.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CNTNAP2
ENST00000361727.8
TSL:1 MANE Select
c.2099-14838T>C
intron
N/AENSP00000354778.3
CNTNAP2
ENST00000455301.2
TSL:3
n.34-14838T>C
intron
N/A
CNTNAP2
ENST00000627772.2
TSL:2
n.272-14838T>C
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.442
AC:
58186
AN:
131516
Hom.:
14826
Cov.:
27
show subpopulations
Gnomad AFR
AF:
0.462
Gnomad AMI
AF:
0.227
Gnomad AMR
AF:
0.449
Gnomad ASJ
AF:
0.559
Gnomad EAS
AF:
0.338
Gnomad SAS
AF:
0.369
Gnomad FIN
AF:
0.382
Gnomad MID
AF:
0.488
Gnomad NFE
AF:
0.445
Gnomad OTH
AF:
0.475
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.442
AC:
58234
AN:
131636
Hom.:
14836
Cov.:
27
AF XY:
0.437
AC XY:
27957
AN XY:
63980
show subpopulations
African (AFR)
AF:
0.462
AC:
18285
AN:
39558
American (AMR)
AF:
0.448
AC:
5661
AN:
12626
Ashkenazi Jewish (ASJ)
AF:
0.559
AC:
1620
AN:
2896
East Asian (EAS)
AF:
0.338
AC:
1402
AN:
4154
South Asian (SAS)
AF:
0.368
AC:
1386
AN:
3762
European-Finnish (FIN)
AF:
0.382
AC:
3411
AN:
8938
Middle Eastern (MID)
AF:
0.487
AC:
113
AN:
232
European-Non Finnish (NFE)
AF:
0.445
AC:
25389
AN:
57070
Other (OTH)
AF:
0.475
AC:
809
AN:
1704
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.462
Heterozygous variant carriers
0
1184
2369
3553
4738
5922
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
516
1032
1548
2064
2580
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.500
Hom.:
78133
Bravo
AF:
0.495
Asia WGS
AF:
0.456
AC:
1590
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.94
CADD
Benign
9.1
DANN
Benign
0.85
PhyloP100
-0.57
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2538976; hg19: chr7-147585819; COSMIC: COSV62153005; API